Has Charles Toulson, MD received payments from drug or device companies?

Yes. Drug and device makers reported $723,241 in general payments to Charles Toulson, MD across 564 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Charles Toulson, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Charles Toulson, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Charles Toulson, MD

Orthopaedic Surgery · McKinney, TXNPI 1780895938

Payments from drug & device makers

$723,241in general payments, 2019–2025

Across 564 payments — averaging $1282.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Omnilife Science, Inc$326K
Encore Medical, LP$188K
Zimmer Biomet$158K
Stryker$45K
Ortho Development Corporation$598
Amgen$509
plus $4K from 38 others

What the payments were for

Royalty or licence$574,29879%
Consulting fees$104,90015%
Travel & lodging$24,6213%
Food & beverage$19,3753%
Education$470%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Omnilife Science, Inc	33	$326,362
Encore Medical, LP	7	$188,187
Zimmer Biomet	204	$158,199
Stryker	156	$45,115
Ortho Development Corporation	5	$598
Amgen(2 entities)	31	$509
Bioventus LLC	13	$493
Kyocera Medical Technologies, Inc.	3	$493
Johnson & Johnson(2 entities)	18	$444
Pacira Pharmaceuticals Incorporated	10	$412
Medical Device Business Services, Inc.	3	$267
Pacira Therapeutics, Inc.	14	$263
Intellijoint Surgical Inc.	1	$228
Shalby Advanced Technologies, Inc.	2	$204
Davol Inc.	8	$175
Bone Support Inc.	1	$147
Philips North America LLC	1	$97
BD	3	$87
Avanos Medical	4	$86
Corin USA	1	$86
Kowa Pharmaceuticals America, Inc.	5	$78
Abbott	3	$62
Innovation Technologies Inc	2	$60
Solventum Corporation	2	$54
Orthofix Medical, Inc.	4	$50
Fidia Pharma USA Inc.	3	$49
Medtronic(2 entities)	3	$45
KCI USA, Inc.	2	$40
Molnlycke Health Care US, LLC	3	$37
Baudax Bio Inc.	2	$34
Baxter Healthcare	1	$32
Theragen, Inc.	2	$30
Integra Lifesciences Corporation	2	$26
Pylant Medical	1	$22
Acera Surgical, Inc.	1	$20
Radius Health, Inc.	1	$20
Biocomposites Inc	2	$20
Kerecis Limited	1	$20
Assertio Therapeutics, Inc.	1	$19
Heraeus Medical, LLC.	1	$18
Urgo Medical North America, LLC	1	$16
Tersera Therapeutics LLC	1	$15
Next Science LLC	1	$14
Sanofi-aventis U.S. LLC	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

DJO Surgical TaperFill Hip System$188,187
ROSA$68,537
MAKO$37,534
PD-Hip-New Product$30,594
PD-Knee-New Product$10,896
ROSA-Knee$5,002
ACCOLADE$3,946
TRIATHLON$3,928
GMRS$3,800
INSIGNIA$1,600
TRIDENT$1,600
RESTORATION$1,600
G7$1,563
Various Products$1,393
OMNIBotics 3.0$1,063
Oxford$1,048
Persona$914
PD-Extremities-New Product$272
EXPAREL$246
Intelljoint$228

How this compares

$723,241 in reported general payments places this provider in the 95th percentile of 1,337 orthopaedic surgery providers in Texas.

See all orthopaedic surgery providers in Texas →

Medicare billing

Part B allowed, 2024

$825,375

Medicare patients

975

Services billed

26,375

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	609	$9,633
EliquisApixaban	22	$6,358
Celecoxib	326	$4,605
Methylprednisolone	222	$1,538
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	82	$1,052
Minocycline Hcl	72	$914
Meloxicam	233	$716
Tramadol Hcl	90	$609
Acetaminophen-CodeineAcetaminophen With Codeine	36	$424
Methocarbamol	52	$325
Gabapentin	52	$303
Ondansetron OdtOndansetron	19	$270
Amoxicillin	157	$172
Ondansetron Hcl	15	$158
Hydrocortisone	17	$129

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in McKinney

Jon ThompsonMcKinney$1.6M
Stephen BurkhartSan Antonio$185.3M
Kirby HittTemple$9.1M
J Richard EvansonPlano$8.1M
Stefan KreuzerHouston$7M
Robert GrahamAustin$6.3M
Richard JonesDallas$6.3M
Howard HarrisBedford$4.6M
Tiffany HuynhHouston$4.6M
Michael WirthSan Antonio$4.5M

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →